Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-18

Clinical Trial Update: Phase 2 Clinical Trial of GH001 in Postpartum Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating GH001 for postpartum depression has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GH001

Snippet

Sponsor: GH Research Ireland Limited | Conditions: Postpartum Depression, Postnatal Depression | Phase 2 | Status: TERMINATED